|
Platelets
Citations 111-120 of 382 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Platelet Adhesion Via Glycoprotein IIb Integrin Is Critical for Atheroprogression and Focal Cerebral Ischemia. An In Vivo Study in Mice Lacking Glycoprotein IIb
- Steffen Massberg, Katrin Schürzinger, Michael Lorenz, Ildiko Konrad, Christian Schulz, Nikolaus Plesnila, Elisabeth Kennerknecht, Martina Rudelius, Susanne Sauer, Siegmund Braun, Elisabeth Kremmer, Nikla R. Emambokus, Jon Frampton, and Meinrad Gawaz
Circulation published August 15, 2005, doi:10.1161/CIRCULATIONAHA.105.539221
[Abstract]
- Special Reports
Cyclooxygenase Inhibition and Cardiovascular Risk
- Elliott M. Antman, David DeMets, and Joseph Loscalzo
Circulation 2005;112:759-770, doi:10.1161/CIRCULATIONAHA.105.568451
[Full text]
- Coronary Heart Disease
Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y12 Antagonist, With Clopidogrel in Percutaneous Coronary Intervention: Results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)–TIMI 26 Trial
- Stephen D. Wiviott, Elliott M. Antman, Kenneth J. Winters, Govinda Weerakkody, Sabina A. Murphy, Bruce D. Behounek, Robert J. Carney, Charles Lazzam, Raymond G. McKay, Carolyn H. McCabe, Eugene Braunwald for the JUMBO–TIMI 26 Investigators
Circulation 2005;111:3366-3373; published online before print as doi:10.1161/CIRCULATIONAHA.104.502815
[Abstract]
[Full text]
- Articles
Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y12 Antagonist, With Clopidogrel in Percutaneous Coronary Intervention. Results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 Trial
- Stephen D. Wiviott, Elliott M. Antman, Kenneth J. Winters, Govinda Weerakkody, Sabina A. Murphy, Bruce D. Behounek, Robert J. Carney, Charles Lazzam, Raymond G. McKay, Carolyn H. McCabe, Eugene Braunwald for the JUMBO-TIMI 26 Investigators
Circulation published June 20, 2005, doi:10.1161/CIRCULATIONAHA.104.502815
[Abstract]
- Editorials
Particulate Pollution and Endothelial Function: Déjà Vu All Over Again in the Air
- Sanjay Rajagopalan, Qinghua Sun, and Lung Chi Chen
Circulation 2005;111:2869-2871, doi:10.1161/CIRCULATIONAHA.105.540872
[Full text]
- Correspondence
Letters Regarding Article by Mehilli et al, "Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel" • Response
- Áurea J. Chaves, Amanda G.M.R. Sousa, John W. Eikelboom, James M. Rankin, Adnan Kastrati, Julinda Mehilli, Helmut Schühlen, Alban Dibra, Jürgen Pache, Albert Schömig, Nicolas von Beckerath, Hildegard Bollwein, Josef Dirschinger, Franz Dotzer, and Peter P. Berger
Circulation 2005;111:e370-371e, doi:10.1161/CIRCULATIONAHA.104.529735
[Full text]
- Editorials
Loading, Pretreatment, and Interindividual Variability Issues With Clopidogrel Dosing
- Eric R. Bates, Wei C. Lau, and Barry E. Bleske
Circulation 2005;111:2557-2559, doi:10.1161/CIRCULATIONAHA.105.536276
[Full text]
- Contemporary Reviews in Cardiovascular Medicine
When Heparins Promote Thrombosis: Review of Heparin-Induced Thrombocytopenia
- Ik-Kyung Jang and Marcie J. Hursting
Circulation 2005;111:2671-2683, doi:10.1161/CIRCULATIONAHA.104.518563
[Full text]
- Special Reports
Cardiovascular Effects of Secondhand Smoke: Nearly as Large as Smoking
- Joaquin Barnoya and Stanton A. Glantz
Circulation 2005;111:2684-2698, doi:10.1161/CIRCULATIONAHA.104.492215
[Abstract]
[Full text]
- Clinician Update
Controversies in Antiplatelet Therapy for Patients With Cardiovascular Disease
- Eric R. Bates and Wei C. Lau
Circulation 2005;111:e267-271e, doi:10.1161/01.CIR.0000157158.63751.B2
[Full text]
|
|
